Russia: COVID-19 vaccine production for civilian circulation to begin a month after 3rd stage
MOSCOW, August 16. /TASS/: The coronavirus vaccine developed by the N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology of the Russian Health Ministry may enter production for civilian circulation a month after the launch of the third stage (post-registration) of the research, the center’s Director Alexander Gintsburg told TASS.
However, not all Russian citizens will be able to get the vaccine at once, he stressed.